ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
HIV Incidence and Participation Retention in Pune, India

This study has been completed.

Sponsored by: National Institute of Allergy and Infectious Diseases (NIAID)
Information provided by: National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier: NCT00028119
  Purpose

The purpose of this study is to ensure that the HIV Prevention Trials Unit (HPTU) in Pune will be able to enroll and retain participants for 2 upcoming HPTN clinical trials. Specifically, this study seeks to find the rate of HIV infection and follow-up among a group of high-risk, HIV-negative non-sexworker women in Pune, as well as among HIV-discordant couples (couples where 1 partner is HIV-infected and the other is not).

Phase III studies of HIV prevention require the participation of a large number of people at high risk for HIV infection. It is also important that these participants continue and follow through with the study through the extended period of follow-up. A measurement of HIV incidence and retention rate among high-risk women and HIV-discordant couples is necessary for upcoming HPTN trials. Taken together with the need for estimates of HIV incidence and the need for data to ensure high retention rates, this protocol is important for the HPTN generally and for HPTU in Pune in particular.


Condition
HIV Infections
HIV Seronegativity

MedlinePlus related topics:   AIDS   

U.S. FDA Resources

Study Type:   Observational
Official Title:   HPTN HIV Incidence and Participant Retention Protocol, Pune, India

Further study details as provided by National Institute of Allergy and Infectious Diseases (NIAID):

Estimated Enrollment:   1070

Detailed Description:

Previous prevention-trial planning efforts have indicated that Phase III studies of HIV prevention interventions will require the participation of large numbers of persons at high risk for HIV infection. In addition to accruing large numbers of participants, research centers conducting Phase III HIV prevention studies must retain participants in extended periods of follow-up in order to accurately reflect the impact of the intervention in the target population. A current measurement of HIV incidence, the risk factors associated with HIV infection, and the retention rate of newly enrolled high-risk women is necessary for an upcoming HPTN trial. In addition, HPTN requires an assessment of its ability to enroll and retain HIV-discordant couples for a proposed HPTN trial, as well as a timely assessment of the HIV incidence rate in these exposed partners. This study will provide essential experience and a preliminary base for the enrollment of discordant couples into future HPTN clinical trials. Taken together with the need for current estimates of HIV incidence in the cohort and community populations and the need for data to ensure high retention rates, this protocol is important for the HPTN generally and for HPTU in Pune in particular.

Potential study participants will undergo eligibility screening, including administration of a questionnaire, physical examination, and HIV antibody testing. Once participants are enrolled in the study, the requirements will include follow-up every 3 months for 17.5 months, phlebotomy, physical exams, and questionnaires. At every follow-up visit, a short questionnaire will be administered to all participants to assess their continued understanding about the nature, duration, benefits and risks of being in the study and to assure their voluntary participation in the study. Participants seen in follow-up also will have a physical examination, be evaluated and treated for any STDs, receive additional counseling, and be offered retesting for HIV infection. In addition, participants also will be invited to participate in additional assessment issues addressing retention using a series of focus groups, key informant interviews, and individual qualitative and quantitative assessments. Participants in this protocol may also be eligible to enroll into 1 of 2 proposed ancillary laboratory substudies (HPTN 034A and 034B).

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria

HIV-uninfected women may be eligible if they are:

  • At least 18 years old.
  • Able and willing to provide written informed consent for HIV testing and to take part in this study.
  • Willing to receive their HIV test results.
  • HIV-negative.
  • Available for at least 17.5 months of study follow-up.

HIV-infected partners (index partner) in the HIV-discordant couples may be eligible if they are:

  • At least 18 years old.
  • Able and willing to provide written consent for HIV testing and to take part in this study.
  • Willing to receive their HIV test results.
  • HIV-positive.
  • Available for at least 17.5 months of study follow-up.
  • Presently in a sexual relationship with the same partner for at least 3 months.
  • Intending to remain with this partner for the duration of the study.
  • Willing to identify his/her sexual partner and disclose his/her HIV status to partner.
  • Willing to attempt to recruit their partner.

Partners of HIV-infected index partners in the HIV-discordant couples may be eligible if they are:

  • At least 18 years old.
  • Able and willing to provide written consent for HIV testing.
  • Willing to receive their HIV test results.
  • HIV-negative.

HIV-discordant couples may be eligible if they first meet the criteria in 2 and 3 above and also if:

  • Each partner agrees to participate in the study together.
  • Each partner is able and willing to provide written informed consent to take part in the study.
  • The partners have been in a sexual relationship for at least the prior 3 months.
  • Each partner is available for at least 17.5 months of study follow-up.
  • Each couple has stated intention to continue their relationship for at least 17.5 months.
  • Each partner is willing and able to attend each scheduled follow-up study visit.

Exclusion Criteria

Persons may not be eligible for this study if they:

  • Are HIV-uninfected women who report a history of prior commercial sex work. However, HIV-infected female commercial sex workers can be enrolled in the HIV-discordant partners study with their HIV-uninfected male sexual partner.
  • Have mental problems that would interfere with study participation.
  • Have any other condition that, in the opinion of the investigator, would interfere with the study.
  • Are an HIV-discordant couple that reports a history of domestic violence.
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00028119

Locations
India
National AIDS Research Institute    
      Pune, India, 411 026

Sponsors and Collaborators

Investigators
Principal Investigator:     Robert Bollinger    
Principal Investigator:     Sanjay Mehendale    
  More Information


Haga clic aquí para ver información sobre este ensayo clínico en español.  This link exits the ClinicalTrials.gov site
 

Study ID Numbers:   HPTN 034, HPTN 034B substudy, HPTN 034A substudy
First Received:   December 13, 2001
Last Updated:   September 16, 2008
ClinicalTrials.gov Identifier:   NCT00028119
Health Authority:   United States: Federal Government

Keywords provided by National Institute of Allergy and Infectious Diseases (NIAID):
Clinical Trials  
Sexual Partners  
Risk Factors  
Incidence  
HIV Seronegativity
India
Patient Compliance
Preventive Health Services

Study placed in the following topic categories:
Virus Diseases
Sexually Transmitted Diseases, Viral
HIV Infections
Sexually Transmitted Diseases
Acquired Immunodeficiency Syndrome
Urinary Retention
Retroviridae Infections
Immunologic Deficiency Syndromes

Additional relevant MeSH terms:
RNA Virus Infections
Slow Virus Diseases
Immune System Diseases
Lentivirus Infections
Infection

ClinicalTrials.gov processed this record on December 03, 2008




Links to all studies - primarily for crawlers